Operational blind spots cost margins and elevate risks for manufacturers. We explore how teams can see these familiar challenges more clearly and solve them more efficiently.
The Pentagon assisted with the deal between the automaker’s subsidiary and the weapons maker. The agreement comes as ...
Vector BioMed COO Michael Kadan explains why the next cancer-care breakthrough may come from expanding CAR-T access through ...
The country’s workforce is set to fall to 300 million by the end of the century and Beijing sees AI-enabled machines as a way ...
Even after numerous FDA warnings, the agency hasn’t stopped Empower Pharmacy from producing drugs at a scale rarely — if ever ...
The launch puts the Dearborn automaker on-track to be the first to deliver U.S.-made lithium-iron phosphate batteries for ...
Campbell's margins are worsening and asset efficiency lags peers—raising dividend cut risk. Fnid out why CPB stock is a Sell.
Rising prices for computers, phones, game consoles, appliances, and cars are just the beginning ...
According to internal financial records, the pharmacy dispensed nearly 3 million individual prescriptions to patients ...
But as the country became shorthand in Australia's debate over immigration and multiculturalism, experts say the comparison ...
Opinion

A cure worse than the disease?

Prescription drug prices are a serious burden in America, and perhaps the chief modern example of why good intentions do not always equal solutions. Take the newly introduced Medication Affordability ...
Opinion

Double trouble

India ends up projecting itself to be larger than it is in the Global South and more central than it is in the Indo-Pacific, while the actual record points to a narrowing of influence ...